Skip to main content
Top
Published in: Malaria Journal 1/2010

Open Access 01-12-2010 | Research

Perspectives of people in Mali toward genetically-modified mosquitoes for malaria control

Authors: John M Marshall, Mahamoudou B Touré, Mohamed M Traore, Shannon Famenini, Charles E Taylor

Published in: Malaria Journal | Issue 1/2010

Login to get access

Abstract

Background

Genetically-modified (GM) mosquitoes have been proposed as part of an integrated vector control strategy for malaria control. Public acceptance is essential prior to field trials, particularly since mosquitoes are a vector of human disease and genetically modified organisms (GMOs) face strong scepticism in developed and developing nations. Despite this, in sub-Saharan Africa, where the GM mosquito effort is primarily directed, very little data is available on perspectives to GMOs. Here, results are presented of a qualitative survey of public attitudes to GM mosquitoes for malaria control in rural and urban areas of Mali, West Africa between the months of October 2008 and June 2009.

Methods

The sample consisted of 80 individuals - 30 living in rural communities, 30 living in urban suburbs of Bamako, and 20 Western-trained and traditional health professionals working in Bamako and Bandiagara. Questions were asked about the cause of malaria, heredity and selective breeding. This led to questions about genetic alterations, and acceptable conditions for a release of pest-resistant GM corn and malaria-refractory GM mosquitoes. Finally, participants were asked about the decision-making process in their community. Interviews were transcribed and responses were categorized according to general themes.

Results

Most participants cited mosquitoes as one of several causes of malaria. The concept of the gene was not widely understood; however selective breeding was understood, allowing limited communication of the concept of genetic modification. Participants were open to a release of pest-resistant GM corn, often wanting to conduct a trial themselves. The concept of a trial was reapplied to GM mosquitoes, although less frequently. Participants wanted to see evidence that GM mosquitoes can reduce malaria prevalence without negative consequences for human health and the environment. For several participants, a mosquito control programme was preferred; however a transgenic release that satisfied certain requirements was usually acceptable.

Conclusions

Although there were some dissenters, the majority of participants were pragmatic towards a release of GM mosquitoes. An array of social and cultural issues associated with malaria, mosquitoes and genetic engineering became apparent. If these can be successfully addressed, then social acceptance among the populations surveyed seems promising.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hay SI, Guerra CA, Tatum AJ, Atkinson PM, Snow RW: Urbanization, malaria transmission and disease burden in Africa. Nat Rev Microbiol. 2005, 3: 81-90. 10.1038/nrmicro1069.PubMedCentralCrossRefPubMed Hay SI, Guerra CA, Tatum AJ, Atkinson PM, Snow RW: Urbanization, malaria transmission and disease burden in Africa. Nat Rev Microbiol. 2005, 3: 81-90. 10.1038/nrmicro1069.PubMedCentralCrossRefPubMed
2.
go back to reference Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI: The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature. 2005, 434: 214-217. 10.1038/nature03342.PubMedCentralCrossRefPubMed Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI: The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature. 2005, 434: 214-217. 10.1038/nature03342.PubMedCentralCrossRefPubMed
3.
go back to reference Molineaux L, Gramiccia G: The Garki Project: Research on the Epidemiology and Control of Malaria in the Sudan Savanna of West Africa. 1980, Geneva, World Health Organization Molineaux L, Gramiccia G: The Garki Project: Research on the Epidemiology and Control of Malaria in the Sudan Savanna of West Africa. 1980, Geneva, World Health Organization
5.
6.
go back to reference Alphey L, Beard CB, Billingsley P, Coetzee M, Crisanti A, Curtis C, Eggleston P, Godfray C, Hemingway J, Jacobs-Lorena M, James AA, Kafatos FC, Mukwaya LG, Paton M, Powell JR, Schneider W, Touré Y, Collins FH: Malaria control with genetically manipulated insect vectors. Science. 2002, 298: 119-121. 10.1126/science.1078278.CrossRefPubMed Alphey L, Beard CB, Billingsley P, Coetzee M, Crisanti A, Curtis C, Eggleston P, Godfray C, Hemingway J, Jacobs-Lorena M, James AA, Kafatos FC, Mukwaya LG, Paton M, Powell JR, Schneider W, Touré Y, Collins FH: Malaria control with genetically manipulated insect vectors. Science. 2002, 298: 119-121. 10.1126/science.1078278.CrossRefPubMed
7.
go back to reference Chen CH, Huang H, Ward CM, Su JT, Schaeffer LV, Guo M, Hay BA: A synthetic maternal-effect selfish genetic element drives population replacement in Drosophila. Science. 2007, 316: 597-600. 10.1126/science. 1138595.CrossRefPubMed Chen CH, Huang H, Ward CM, Su JT, Schaeffer LV, Guo M, Hay BA: A synthetic maternal-effect selfish genetic element drives population replacement in Drosophila. Science. 2007, 316: 597-600. 10.1126/science. 1138595.CrossRefPubMed
8.
go back to reference Bohannon J: Zambia rejects GM corn on scientists' advice. Science. 2002, 298: 1153-1154. 10.1126/science.298.5596.1153a.CrossRefPubMed Bohannon J: Zambia rejects GM corn on scientists' advice. Science. 2002, 298: 1153-1154. 10.1126/science.298.5596.1153a.CrossRefPubMed
9.
go back to reference Heller R: GM Nation? The Findings of the Public Debate. 2003, London, Department of Trade and Industry Heller R: GM Nation? The Findings of the Public Debate. 2003, London, Department of Trade and Industry
10.
go back to reference Macer D: Ethics and community engagement for GM insect vector release. Genetically Modified Mosquitoes for Malaria Control. Edited by: Boëte C. 2005, Austin, TX, Landes Bioscience, 1-14. Macer D: Ethics and community engagement for GM insect vector release. Genetically Modified Mosquitoes for Malaria Control. Edited by: Boëte C. 2005, Austin, TX, Landes Bioscience, 1-14.
11.
go back to reference Scott TW, Takken W, Knols BG, Boëte C: The ecology of genetically modified mosquitoes. Science. 2002, 298: 117-119. 10.1126/science.298.5591.117.CrossRefPubMed Scott TW, Takken W, Knols BG, Boëte C: The ecology of genetically modified mosquitoes. Science. 2002, 298: 117-119. 10.1126/science.298.5591.117.CrossRefPubMed
12.
go back to reference Knols BGJ, Bossin HC, Mukabana WR, Robinson AS: Transgenic mosquitoes and the fight against malaria: Managing technology push in a turbulent GMO world. Am J Trop Med Hyg. 2007, 77: 232-242.PubMed Knols BGJ, Bossin HC, Mukabana WR, Robinson AS: Transgenic mosquitoes and the fight against malaria: Managing technology push in a turbulent GMO world. Am J Trop Med Hyg. 2007, 77: 232-242.PubMed
13.
go back to reference Lavery JV, Harrington LC, Scott TW: Ethical, social and cultural considerations for site selection for research with genetically modified mosquitoes. Am J Trop Med Hyg. 2008, 79: 312-318.PubMed Lavery JV, Harrington LC, Scott TW: Ethical, social and cultural considerations for site selection for research with genetically modified mosquitoes. Am J Trop Med Hyg. 2008, 79: 312-318.PubMed
14.
go back to reference Benedict M, D'Abbs P, Dobson S, Gottlieb M, Harrington L, Higgs S, James A, James S, Knols B, Lavery J, O'Neill S, Scott T, Takken W, Touré Y: Guidance for contained field trials of vector mosquitoes engineered to contain a gene drive system: recommendations of a scientific working group. Vector-Borne Zoonotic Dis. 2008, 8: 127-166. 10.1089/vbz.2007.0273.CrossRefPubMed Benedict M, D'Abbs P, Dobson S, Gottlieb M, Harrington L, Higgs S, James A, James S, Knols B, Lavery J, O'Neill S, Scott T, Takken W, Touré Y: Guidance for contained field trials of vector mosquitoes engineered to contain a gene drive system: recommendations of a scientific working group. Vector-Borne Zoonotic Dis. 2008, 8: 127-166. 10.1089/vbz.2007.0273.CrossRefPubMed
15.
go back to reference Macer D, Howard B, Harman N, Kamada H, Macer NY: Attitudes to biotechnology in Japan and New Zealand in 1997, with international comparisons. Eubios Journal of Asian and International Bioethics. 1997, 7: 137-151. Macer D, Howard B, Harman N, Kamada H, Macer NY: Attitudes to biotechnology in Japan and New Zealand in 1997, with international comparisons. Eubios Journal of Asian and International Bioethics. 1997, 7: 137-151.
16.
go back to reference Ng MAC, Takeda C, Watanabe T, Macer D: Attitudes of the public and scientists to biotechnology in Japan at the start of 2000. Eubios Journal of Asian and International Bioethics. 2000, 10: 106-113.PubMed Ng MAC, Takeda C, Watanabe T, Macer D: Attitudes of the public and scientists to biotechnology in Japan at the start of 2000. Eubios Journal of Asian and International Bioethics. 2000, 10: 106-113.PubMed
17.
go back to reference Pew Initiative on Food and Biotechnology: Public Sentiment about Genetically Modified Food. 2006, New York, Pew Charitable Trusts Pew Initiative on Food and Biotechnology: Public Sentiment about Genetically Modified Food. 2006, New York, Pew Charitable Trusts
18.
go back to reference Masakazu I, Macer D: Attitudes to biotechnology in Japan in 2003. Eubios Journal of Asian and International Bioethics. 2003, 13: 78-90. Masakazu I, Macer D: Attitudes to biotechnology in Japan in 2003. Eubios Journal of Asian and International Bioethics. 2003, 13: 78-90.
19.
go back to reference Tripet F, Dolo G, Traore S, Lanzaro GC: Multilevel analyses of genetic differentiation in Anopheles gambiae s.s. reveal patterns of gene flow important for malaria-fighting mosquito projects. Genetics. 2005, 169: 313-324. 10.1534/genetics.104.026534.PubMedCentralCrossRefPubMed Tripet F, Dolo G, Traore S, Lanzaro GC: Multilevel analyses of genetic differentiation in Anopheles gambiae s.s. reveal patterns of gene flow important for malaria-fighting mosquito projects. Genetics. 2005, 169: 313-324. 10.1534/genetics.104.026534.PubMedCentralCrossRefPubMed
20.
go back to reference Library of Congress: Country Profile: Mali. 2005, Washington, DC, United States Government Library of Congress: Country Profile: Mali. 2005, Washington, DC, United States Government
21.
go back to reference Taylor CE, Touré YT, Carnahan J, Norris DE, Dolo G, Traoré SF, Edillo FE, Lanzaro GC: Gene flow among populations of the malaria vector Anopholes gambiae, in Mali, West Africa. Genetics. 2001, 157: 743-750.PubMedCentralPubMed Taylor CE, Touré YT, Carnahan J, Norris DE, Dolo G, Traoré SF, Edillo FE, Lanzaro GC: Gene flow among populations of the malaria vector Anopholes gambiae, in Mali, West Africa. Genetics. 2001, 157: 743-750.PubMedCentralPubMed
22.
go back to reference Secretariat of the Convention on Biological Diversity: Cartagena Protocol on Biosafety to the Convention on Biological Diversity. 2000, Montreal, World Trade Center Secretariat of the Convention on Biological Diversity: Cartagena Protocol on Biosafety to the Convention on Biological Diversity. 2000, Montreal, World Trade Center
23.
go back to reference Imperato PJ: African Folk Medicine. 1977, Baltimore, York Press Inc Imperato PJ: African Folk Medicine. 1977, Baltimore, York Press Inc
24.
go back to reference Macer D: Ethical, Legal and Social Issues of Genetically Modified Disease Vectors in Public Health. 2003, Geneva, World Health Organization Macer D: Ethical, Legal and Social Issues of Genetically Modified Disease Vectors in Public Health. 2003, Geneva, World Health Organization
Metadata
Title
Perspectives of people in Mali toward genetically-modified mosquitoes for malaria control
Authors
John M Marshall
Mahamoudou B Touré
Mohamed M Traore
Shannon Famenini
Charles E Taylor
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2010
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-9-128

Other articles of this Issue 1/2010

Malaria Journal 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.